A. Pandita

发表

The mutation spectrum revealed by paired genome sequences from a lung cancer patient

A. Sparks, M. Kennemer, K. Pant, 2010, Nature.

Mapping of the gene encoding the integrin-linked kinase, ILK, to human chromosome 11p15.5-p15.4.

R. Weksberg, S. Dedhar, J. Squire, 1997, Genomics.

Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.

Zhaoshi Jiang, Somasekar Seshagiri, Franklin Peale, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

COP1 is a tumour suppressor that causes degradation of ETS transcription factors

K. Leong, V. Dixit, Jinfeng Liu, 2011, Nature.

Evaluation of Sphingomonas paucimobilis as an emerging nosocomial pathogen in a teaching hospital in Uttarakhand

A. Pandita, Malvika Singh, Ranjana Rohilla, 2021, Iranian journal of microbiology.

A Prospective Comparative Study among Adult and Geriatric Smear Positive Pulmonary Tuberculosis Patients in a Tertiary Care Hospital of Dehradun, Uttarakhand -

A. Pandita, Dimple Raina, D. Sardana, 2017 .

Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

C. James, J. Sarkaria, P. Brown, 2006, Clinical Cancer Research.

Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.

P. Sorensen, J. Squire, A. Petrilli, 2001, Cancer genetics and cytogenetics.

Final efficacy results from OAM4558g, a randomized phase II study evaluating MetMAb or placebo in combination with erlotinib in advanced NSCLC.

R. Govindan, R. Ramlau, M. Krzakowski, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experimental candidiasis in Japanese quail: Pathological changes

A. Pandita, R. Asrani, J. R. Sadana, 1993, Mycopathologia.

Studies on clinical signs and haematological alterations in pneumonic aspergillosis due to Aspergillus flavus in Japanese quail

A. Pandita, R. Asrani, J. R. Sadana, 1991, Mycopathologia.

Molecular cytogenetic analysis in the study of brain tumors: findings and applications.

J. Squire, J. Bayani, A. Pandita, 2005, Neurosurgical focus.

Integrated Cytogenetic and High-Resolution Array CGH Analysis of Genomic Alterations Associated with MYCN Amplification

J. Squire, J. Bayani, A. Pandita, 2011, Cytogenetic and Genome Research.

Prevalence of Hepatitis B and Hepatitis C in Patients undergoing hemodialysis at a teaching hospital in Uttarakhand

A. Pandita, N. Rawat, Dimple Raina, 2022, Journal of family medicine and primary care.

Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR

K. Aldape, G. Zadeh, A. Guha, 2004, Genes, chromosomes & cancer.

PPM1H is a p27 phosphatase implicated in trastuzumab resistance.

David P. Davis, G. Turashvili, S. Aparicio, 2011, Cancer discovery.

A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma.

C. James, G. Eley, Soyeon Park, 2002, Neuro-oncology.

The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors

J. Squire, M. Meyn, A. Pandita, 2002, Genes, chromosomes & cancer.

Acquired PIK3CA amplification causes resistance to selective phosphoinositide 3-kinase inhibitors in breast cancer

G. Hampton, Yulei N. Wang, T. Wilson, 2013, Oncogenesis.

Malignant and benign ganglioglioma: a pathological and molecular study.

P. Shannon, A. Guha, A. Pandita, 2007, Neuro-oncology.

Molecular cytogenetic analysis and gene amplification in rhabdomyosarcoma and neuroblastoma

A. Pandita, 2000 .

Molecular Biomarker Analyses Using Circulating Tumor Cells

Ru-Fang Yeh, Bernard M. Fine, R. Yeh, 2010, PloS one.

Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

J. Squire, R. Godbout, J. Bayani, 1999, Neoplasia.

Oncogenic Activating Mutations Are Associated with Local Copy Gain

L. Garraway, G. Cavet, B. Modrek, 2009, Molecular Cancer Research.

Exon Array Profiling Detects EML4-ALK Fusion in Breast, Colorectal, and Non–Small Cell Lung Cancers

Li Li, Zora Modrusan, Jerry Tang, 2009, Molecular Cancer Research.

Phosphoinositide 3-Kinase (PI3K) Pathway Alterations Are Associated with Histologic Subtypes and Are Predictive of Sensitivity to PI3K Inhibitors in Lung Cancer Preclinical Models

G. Hampton, J. Fridlyand, J. Spoerke, 2012, Clinical Cancer Research.

Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas

P. Sorensen, J. Squire, J. Bayani, 2003, Genes, chromosomes & cancer.

Comparative genomic hybridization analysis identifies gains of 1p35 p36 and chromosome 19 in osteosarcoma

P. Sorensen, J. Squire, A. Petrilli, 2001 .

CD40 Pathway Activation Status Predicts Response to CD40 Therapy in Diffuse Large B Cell Lymphoma

Jeffrey T. Lau, R. Advani, S. de Vos, 2011, Science Translational Medicine.

Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer.

Guy Cavet, Carol O'Brien, Zora Modrusan, 2008, Cancer research.

Sequential G-banding, SKY and FISH provide a refined identification of translocation breakpoints and complex chromosomal rearrangements

J. Squire, J. Bayani, A. Pandita, 1999 .

Application of a simplified comparative genomic hybridization technique to screen for gene amplification in pediatric solid tumors.

J. Squire, J. Bayani, A. Pandita, 1995, Pediatric pathology & laboratory medicine : journal of the Society for Pediatric Pathology, affiliated with the International Paediatric Pathology Association.

Genetic analysis of early- versus late-stage ovarian tumors.

G. Mills, F. Couch, S. Iturria, 2001, Cancer research.

Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

I. Wistuba, J. Zha, L. Rangell, 2014, Clinical Cancer Research.

Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.

R. Pieper, A. Pandita, Tracy T. Chow, 2018, Cancer research.

A subset of PARP inhibitors induces lethal telomere fusion in ALT-dependent tumor cells

R. Bjerkvig, R. Pieper, A. Pandita, 2021, Science Translational Medicine.

Chk1 inhibition in p53-deficient cell lines drives rapid chromosome fragmentation followed by caspase-independent cell death

J. Zha, L. Rangell, P. Jackson, 2013, Cell cycle.

A chromosomal region 7 p 11 . 2 transcript map : Its development and application to the study of EGFR amplicons in glioblastoma 1

C. James, G. Eley, Soyeon Park, 2001 .